Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Perrine Soret

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Annals of the Rheumatic Diseases|December 25, 2025
Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's diseaseBaptiste Chevet, Valérie Devauchelle-Pensec, Elena Pontarini, et al.
Nature Communications|August 31, 2023
Antibody-mediated neutralization of galectin-3 as a strategy for the treatment of systemic sclerosisCéline Ortega-Ferreira, Perrine Soret, Gautier Robin, et al.
Nature Communications|June 11, 2021
A new molecular classification to drive precision treatment strategies in primary Sjögren's syndromePerrine Soret, Christelle Le Dantec, Emiko Desvaux, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Annals of the Rheumatic Diseases|December 25, 2025
Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's diseaseBaptiste Chevet, Valérie Devauchelle-Pensec, Elena Pontarini, et al.
Nature Communications|August 31, 2023
Antibody-mediated neutralization of galectin-3 as a strategy for the treatment of systemic sclerosisCéline Ortega-Ferreira, Perrine Soret, Gautier Robin, et al.
Nature Communications|June 11, 2021
A new molecular classification to drive precision treatment strategies in primary Sjögren's syndromePerrine Soret, Christelle Le Dantec, Emiko Desvaux, et al.
Pageof 2